SCHEMBL15224031

SCHEMBL15224031

CCC(=O)c1cc2cc(N)ccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.55
PLG P00747 1/20 0.54
PLAU P00749 1/20 0.54
CYP2A6 P11509 1/20 0.50
KEAP1 Q14145 1/20 0.50
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MMP2 P08253 1/20 0.46
MMP13 P45452 1/20 0.46
PIN1 Q13526 1/20 0.45
PDGFRB P09619 3/20 0.44
ABL1 P00519 1/20 0.44
KIT P10721 1/20 0.44
BCR P11274 1/20 0.44
FLT3 P36888 1/20 0.44
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18792640 0.83 HRH4 (0.51) HRH4CYP2A6KEAP1KDM4EALDH1A1
SCHEMBL25139729 0.82 RAB9A (0.68) HRH4PLGPLAUKDM4EALDH1A1
SCHEMBL12862877 0.81 HRH4 (0.58) HRH4CYP2A6KEAP1KDM4EALDH1A1
SCHEMBL30270477 0.81 KDM4E (0.66) HRH4PLGPLAUKDM4EALDH1A1
SCHEMBL2732294 0.81 FLT3 (0.57) HRH4PLGPLAUKDM4EALDH1A1
SCHEMBL24196169 0.81 KDM4E (0.66) HRH4PLGPLAUKDM4EALDH1A1
SCHEMBL24019647 0.81 F7 (0.66) HRH4RAB9AFLT3NPC1HRH3
SCHEMBL12452817 0.80 MAOA (0.51) PLGPLAUKDM4ERAB9ASMN1; SMN2
SCHEMBL12848263 0.80 ALOX15 (0.58) HRH4CYP2A6KEAP1KDM4EALDH1A1
SCHEMBL656018 0.80 KDM4E (0.74) HRH4CYP2A6KEAP1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130224227-A1 NOVEL CONJUGATES OF CC-1065 ANALOGS AND BIFUNCTIONAL LINKERS BYONDIS B.V. (NL) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130224227-A1 NOVEL CONJUGATES OF CC-1065 ANALOGS AND BIFUNCTIONAL LINKERS PCNA, DCLRE1A, CDC5L HRH4 2715/4885PLG 3678/4885PLAU 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.